DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Entero Healthcare Solutions Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 6 Jul·6 Jul 2026, 12:28 pm

Entero Healthcare Solu L

Entero Healthcare Solutions Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Affected stocks

Neutral1 stock

Entero Healthcare Solu L

ENTERO Neutral

₹1,212.40

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

Concerns Entero Healthcare Solu L (ENTERO).
Category: Company.

Why it matters

A routine update for Entero Healthcare Solu L. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

DR. LAL Path Labs

Dr. Lal Path Labs Ltd. — Options to purchase securities ESOPS (Sub-para 10-Para B)

DR. LAL Path Labs₹1,687.10▲ 0.00%

NSE · 8 min ago

DR. LAL Path Labs

Dr. Lal Path Labs Ltd. — Acquisition (including agreement to acquire)-XBRL

DR. LAL Path Labs₹1,687.10▲ 0.00%

NSE · 9 min ago

Financially Strong Stock to Buy Now for an Upside of 47%; Recommended by Jefferies

Vishal Mega Mart₹109.87▲ 0.00%

Trade Brains · 11 min ago

DR. LAL Path Labs

Dr. Lal Path Labs Ltd. — Outcome of Board Meeting-XBRL

DR. LAL Path Labs₹1,687.10▲ 0.00%

NSE · 12 min ago

Hindustan Foods

Hindustan Foods Limited — Strikes/Lockouts/Disturbances

Hindustan Foods₹568.45▲ 0.00%

NSE · 13 min ago

Silkflex Polymers India L

Silkflex Polymers (India) Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

Silkflex Polymers India L₹193.75▲ 0.00%

NSE · 14 min ago

Dalmia Bharat Q1 PAT Stands at ₹192 Cr; Completes JP Associates Asset Acquisition

Dalmia Bharat₹1,854.70▲ 0.00%

Trade Brains · 14 min ago

Ramkrishna Forgings

Ramkrishna Forgings Limited — Investor Presentation

Ramkrishna Forgings₹584.00▲ 0.00%

NSE · 14 min ago

CG Power Q1 Net Profit Rises 16% to ₹313 Cr; Approves ₹35 Cr GIS Plant Expansion

Trade Brains · 14 min ago

Latest headlines

More news

RBI ramps up rupee support across markets as currency faces pressure, traders say

BusinessLine · 10 min ago

Global market: Euro zone bond yields ease after multi-year highs as oil retreats below $100

Economic Times · 12 min ago

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.